Medicine and Science from The BMJ

The BMJ brings you interviews with the people who are shaping medicine and science around the world.

  1. Nov 6

    Forever chemicals, cosmetic fillers, and LGBTQ+ data

    In this magazine episode, we talk about the forever chemicals in our blood, how to protect patients from cosmetic procedures gone wrong, and the long-standing dearth of LGBTQ+ data.   Per- and poly-fluoro-alkyl substances, also called PFAS or "forever chemicals", have become ubiquitous in our environment over the last 70 years. As the UK government launches a new epidemiological study into human exposure, we discuss the persistent biological effects of PFAS and what this means for long-term health outcomes.   Also this week, we turn our attention to the up-and-coming new restrictions in England targeting non-surgical cosmetic procedures. But will these proposed changes actually protect the public from unscrupulous providers? We discuss the problems with regulation in a profit driven market, and what it means for patient safety.   Finally, while health outcomes for LGBTQ+ people are known to be worse than the general population, the extent of that gap, and what’s causing it, are still difficult to study. Basic data collection is shockingly poor. We hear why that is, and what’s needed to fill the gap.   Guest List: Tony Fletcher – Honorary associate professor at the London School of Hygiene & Tropical Medicine Alexandra Mullock – Senior lecturer in medical law at the University of Manchester Joel Bates – Research assistant at King’s College London   Reading: PFAS: the persistent problem of forever chemicals and health Delayed regulation of non-surgical cosmetic procedures threatens patient safety The NHS doesn’t routinely collect data on LGBTQ+ health, even though meaningful improvements can’t happen without it

  2. Nov 3

    How to track a measles outbreak across Canada, and the ‘loneliness problem’ hitting resident doctors

    In this episode of the Medicine and Science podcast, we dive into a cross-border public health mystery and hear about the loneliness of the resident doctor. Canada recently lost its measles elimination status following a major outbreak of over 2,000 cases that began in late 2024. It's essential that public health agencies can track the virus as it moves through a population - but how do they do it? Two public health physicians from Ontario join us to explain how they went into full investigatory mode. We discuss how genomic sequencing, contact tracing, and vaccination data came together to form a detective story that exposes the vulnerability of under-vaccinated populations, the porous nature of international borders, and what it will take to regain elimination status. Then, we turn to the ongoing retention and morale crisis among resident doctors in the UK. A new BMJ opinion piece points to a possible different fuel for the discontent: workplace loneliness. We explore how rotational placements are stripping away crucial support networks, isolating young doctors on the wards, and what must be done to restore vital connectedness to the profession. Guest List: Dr. Sarah E. Wilson – Public Health Physician in Toronto, Ontario. Dr. Miriam Klassen – Medical Officer of Health in Stratford, Ontario. Alex Mafi – Resident doctor in London  Reading List: Impact of a large measles outbreak associated with transmission in the Americas and Canada’s loss of measles elimination status: descriptive cohort study  Loneliness at work: We need to restore connectedness for resident doctors

  3. Oct 16

    Is robotic joint surgery worth the cost & the prevalence of prescribing cascades

    In this episode of podcast we explore two clinical dilemmas - unrecognised drug side effects, and the outcomes from hip and knee replacements. When an unrecognised adverse drug effect is mistaken for a new symptom, the resulting prescribing cascade can end in polypharmacy and potentially preventable patient harm. New research on nearly 2.3 million adults in Ontario, has found 24 high-priority, potentially inappropriate prescribing cascades—including laxatives after iron, pain relievers following statins, and sedatives after cholinesterase inhibitors. Paula Rochon, Jerry Gurwitz, and Antonio Cherubini, three of the study's authors join us to discuss. Over 100,000 hip and, 100,000 knee replacements are performed annually in the NHS, and health systems are investing hundreds of millions to rapidly scale robot-assisted surgery, but is this expensive new tech delivering better patient outcomes? Two target trial emulation papers, using the UK's National Joint registry aim to find out if robots are better at join replacement. Hassan Mohammad, one of the papers' authors shares their findings, and Teppo Järvinen joins the conversation to discuss challenging orthopaedic surgery standard practice. Guest List Prescribing Cascades Discussion Paula Rochon, Geriatrician, senior scientist, and professor at Sinai Health and the University of Toronto. Jerry Gurwitz, Geriatrician, researcher, and professor of Medicine at UMass Chan Medical School. Antonio Cherubini, Geriatrician and clinical eesearcher at Università Politecnica delle Marche and INRCA (Istituto Nazionale di Riposo e Cura per Anziani)  Robotic Hip & Knee Arthroplasty Discussion Hassan Mohammad, academic clinical lecturer in orthopaedics at Barts and The London School of Medicine and Dentistry Teppo Järvinen, orthopaedic surgeon and professor at the University of Helsinki, and Head of the Finnish Centre for Evidence-Based Orthopaedics (FICEBO) in Finland. BMJ.com Reading List Research Papers Exploring high priority potentially inappropriate prescribing cascades in older adults: population level retrospective cohort study Early national comparison of robotic versus conventional knee replacements for arthritis using National Joint Registry data: target trial emulation study Early national comparison of robotic versus conventional hip replacements for arthritis using National Joint Registry data: target trial emulation study Robot assisted hip and knee arthroplasty: It is high tech, but is it better?

4.5
out of 5
32 Ratings

About

The BMJ brings you interviews with the people who are shaping medicine and science around the world.

More From BMJ Podcasts

You Might Also Like